Krystal Biotech (KRYS) Just Changed Gene Therapy Forever—Smart Investors Are Paying Attention
Krystal Biotech, Inc. (NASDAQ: KRYS) is a cutting-edge biotechnology company pioneering the development of redosable genetic medicines aimed…
Seres Therapeutics (MCRB): The $100M Microbiome Gem Flying Under Wall Street’s Radar
Seres Therapeutics, Inc. (NASDAQ:MCRB) is a pioneering biotechnology company at the forefront of developing microbiome therapeutics—a groundbreaking class…
Telesurgery Is Here—and Intuitive Surgical (ISRG) Owns It
Intuitive Surgical, Inc., founded in 1995 and headquartered in Sunnyvale, California, is a trailblazer in the field of…
Medpace (MEDP) Just Soared 50%—Is This the Most Underrated Biotech Play of 2025?
Medpace Holdings Inc. (NASDAQ:MEDP) is a leading global contract research organization (CRO) that partners with biopharmaceutical, biotechnology, and…
TransMedics (TMDX) Could Be the Tesla of Transplants — Here’s Why Investors Are Paying Attention
TransMedics Group, Inc. (NASDAQ:TMDX) is a pioneering medical technology company that is fundamentally transforming the landscape of organ…
Astera Labs (ALAB) is Down from Highs — But Here’s Why It’s About to Rebound Hard
Astera Labs Inc. (NASDAQ:ALAB) is a rapidly emerging leader in intelligent connectivity solutions designed to address the unique…
Wall Street Sees 75% Upside: Is Replimune (REPL) the Best Biotech Stock to Buy Now?
Replimune Group, Inc. (NASDAQ:REPL) is a biotechnology company pioneering a transformative class of cancer therapeutics based on its…
Smart Investors Are Loading Up on GlucoTrack (GCTK) Before Q3 Milestones
GlucoTrack Inc. (NASDAQ:GCTK) is a medical technology company revolutionizing diabetes management through the development of its innovative continuous…
Pasithea Therapeutics (KTTA) Just Raised $5 Million—Is This the Spark it Needed?
Pasithea Therapeutics Corp. (NASDAQ:KTTA) is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for central…
CNS Pharmaceuticals (CNSP) Might Be 2025’s Most Explosive Biotech Play
CNS Pharmaceuticals Inc. (NASDAQ:CNSP) is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel treatments…
Nature’s Sunshine (NATR) is Crushing Expectations—Is a 2025 Rally Imminent?
Nature’s Sunshine Products Inc. (NASDAQ:NATR) is a global leader in the natural health and wellness industry, known for…
The Honest Company (HNST) Could Be Wall Street’s Most Underrated Clean Brand Stock Right Now
The Honest Company Inc. (NASDAQ:HNST) is a mission-driven consumer goods company that has redefined the standards of transparency,…
Tivic Health (TIVC) Could Skyrocket in 2025
Tivic Health Systems, Inc. (NASDAQ:TIVC) is a forward-looking healthcare technology company headquartered in Fremont, California, dedicated to transforming…
Axogen (AXGN) is Reinventing Nerve Repair—And It Could Make Early Investors Rich
Axogen Inc. (NASDAQ:AXGN) is a pioneering medical technology company dedicated to improving the lives of patients suffering from…
Pharvaris (PHVS): The $300M Biotech that Could Be the Next Big Thing in Pharma
Pharvaris N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel oral therapies for patients suffering from hereditary…
Abeona Therapeutics (ABEO) s Set to Breakeven—And Analysts Say It’s Just the Beginning
Abeona Therapeutics Inc. (NASDAQ:ABEO) is a clinical-stage biopharmaceutical company pioneering gene and cell therapies aimed at treating rare…
Vigil Neuroscience (VIGL): The Tiny Biotech Sanofi Just Bet $600M On
Vigil Neuroscience Inc. is a clinical-stage biotechnology company pioneering a new approach to treating neurodegenerative diseases by focusing…
Agios (AGIO) Could Explode in 2025—And It’s Not Just Hype
Agios Pharmaceuticals Inc. is a pioneering biotechnology company headquartered in Cambridge, Massachusetts, that has become synonymous with cellular-metabolism…